Home page  |  About this library  |  Help  |  Clear       English  |  French  |  Spanish  
Expand Document
Expand Chapter
Full TOC
Preferences
to previous section to next section

close this bookRespuesta de la Salud Pública a las Armas Biológicas y Químicas - Guía de la WHO - Segunda Edición (OPS; 2003; 302 paginas) [EN] [RU] View the PDF document
View the documentPrefacio a la edición en español
View the documentPrólogo
View the documentAgradecimientos
View the documentResumen ejecutivo
View the documentAbreviaturas y acrónimos
View the documentLista de colaboradores
open this folder and view contents1. Introducción
open this folder and view contents2. Evaluación de la amenaza a la salud pública
open this folder and view contents3. Agentes biológicos y químicos
open this folder and view contents4. Preparación y respuesta en salud pública
open this folder and view contents5. Aspectos legales
open this folder and view contents6. Fuentes internacionales de asistencia
close this folderAnexo 1: Agentes químicos
View the document1. Introducción
open this folder and view contents2. Productos químicos letales
open this folder and view contents3. Productos químicos incapacitantes
View the documentBibliografía
View the documentLecturas adicionales
open this folder and view contentsAnexo 2: Toxinas
open this folder and view contentsAnexo 3: Agentes biológicos
open this folder and view contentsAnexo 4: Principios de protección
open this folder and view contentsAnexo 5: Precauciones contra el sabotaje de agua potable, alimentos y otros productos
open this folder and view contentsAnexo 6: Fuentes de información
View the documentAnexo 7: Afiliación de los estados miembro de la OMS a los tratados internacionales sobre armas químicas y biológicas
View the documentCubierta Posterior
 

Bibliografía

1. Khateri S. Statistical views on late complications of chemical weapons on Iranian CW victims. The ASA Newsletter, No. 85, 31 August 2001:1, 16 - 19.

2. Mazandarani M. Secretary-General of the Association for Helping Victims of Iraq's Chemical Warfare with Iran. Statement reported by the Islamic Republic News Agency, 1 December 1996; Web site: http://www.irna.com/en/about/index.shtml.

3. Gosden C et al. Examining long-term severe health consequences of CBW use against civilian populations. Disarmament Forum, 1999, No. 3:67 - 71.

4. Phosgene. Geneva, World Health Organization, 1997 (Environmental Health Criteria, No. 193).

5. Diller WF. Pathogenesis of phosgene poisoning. Toxicology and Industrial Health, 1985, 1:7 - 15.

6. Diller WF. Early diagnosis of phosgene overexposure. Toxicology and Industrial Health, 1985, 1:73 - 80.

7. Diller WF. Late sequelae after phosgene poisoning: a literature review. Toxicology and Indus- trial Health, 1985, 1:129 - 136.

8. Regan RA. Review of clinical experience in handling phosgene exposure cases. Toxicology and Industrial Health, 1985, 1:69 - 72.

9. Wells BA. Phosgene: a practitioner's viewpoint. Toxicology and Industrial Health, 1985, 1:81 - 92.

10. Chloropicrin. Hamilton, ON, Canadian Centre for Occupational Health and Safet, (CHEMINFO No. 2000 - 2003); disponible en http://ccinfoweb.ccohs.ca/cheminfo/Action.lasso and http://www.ccohs.ca/products/databases/cheminfo.html.

11. Hayes WJ. Pesticides studied in man. Baltimore, MD, Williams & Wilkins.

12. Condie LW et al. Ten and ninety-day toxicity studies of chloropicrin in Sprague-Dawley rats. Drug and Chemical Toxicology, 1994, 17:125 - 137.

13. Berck B. Analysis of fumigants and fumigant residues. Journal of Chromatographic Science, 1975, 13:256 - 267.

14. Spencer EY. Guide to the chemicals used in crop protection, 7th ed. Ottawa, Information Canada (Publication 1093).

15. Harris DK. Polymer-fume fever. Lancet, 1951, ii:1008 - 1011.

16. Urbanetti, JS. Toxic inhalational injury. In: Sidell F, Takafuji ET, Franz DR, eds. Medical aspects of chemical and biological warfare. Washington, DC, Department of the Army, Office of The Surgeon General and Borden Institute, 1997.

17. Maidment MP, Rice P, Upshall DG. Retention of inhaled hexafluorocyclobutene in the rat. Journal of Applied Toxicology, 1994, 14:395 - 400.

18. Robbins JJ, Ware RL. Pulmonary edema from Teflon fumes. New England Journal of Medicine, 1964, 271:360 - 361.

19. Lewis CE, Kerby GR. An epidemic of polymer-fume fever. Journal of the American Medical Association, 1965, 191:103 - 106.

20. Williams N, Atkinson W, Patchefsky AS. Polymer-fume fever: not so benign. Journal of Occupational Medicine, 1974, 16:519 - 522.

21. Lailey AF. Oral N-acetlycysteine protects against perfluoroisobutene toxicity in rats. Human and Experimental Toxicology, 1997, 16:212 - 221.

22. Lailey AF et al. Protection by cysteine esters against chemically induced pulmonary oedema. Biochemical Pharmacology, 1991, 42:S47 - S54.

23. Isom GE, Way JL. Effects of oxygen on the antagonism of cyanide intoxication: cytochrome oxidase, in vitro. Toxicology and Applied Pharmacology, 1984, 74:57 - 62.

24. Cyanides. Washington, DC, United States Environmental Protection Agency, 1980 (EPA#440/5-80-037) disponible en http://www.epa.gov/ost/pc/ambientwqc/cyanides80.pdf; Web site: http://www.epa.gov/waterscience/pc/ambient2.html.

25. Marrs TC, Maynard RL, Sidell FR. Chemical warfare agentes: toxicology and treatment. Chichester, Wiley, 1996.

26. Vedder EB. The medical aspects of chemical warfare. Baltimore, MD, Williams & Wilkins, 1925.

27. Sidell FR, Patrick WC, Dashiell TR. Jane's chem-bio handbook. Coulsdon, England, Jane's Information Group, 1998.

28. Ellenhorn MD et al. Ellenhorn's medical toxicology: diagnosis and treatment of human poisoning, 2nd ed. Baltimore, MD, Williams & Wilkins, 1997:1299 - 1300.

29. Dreisbach RH. Handbook of poisoning: prevention, diagnosis and treatment. Los Altos, CA, Lange Medical, 1980.

30. Warthin AS, Weller CV. The medical aspects of mustard gas poisoning. London, Henry Kimpton, 1919.

31. Alexander SF. Medical report of the Bari Harbor mustard casualties. The Military Surgeon, 1947, 101:1 - 17.

32. Willems JL. Chemical management of mustard gas casualties. Annales Medicinae Militaris Belgicae, 1989, 3(Suppl.):1 - 61.

33. Benschop HP et al. Verification of exposure to sulfur mustard in two casualties of the Iran - Iraq conflict. Journal of Analytical Toxicology, 1997, 21:249 - 251.

34. Black RM, Read RW. Biological fate of sulphur mustard, 1,1-thiobis(2-chloroethane): identification of -lyase metabolites and hydrolysis products in urine. Xenobiotica, 1995, 25:167 - 173.

35. Rice P et al. Dermabrasion - a novel concept in the surgical management of sulphur mustard injuries. Burns, 2000, 26:34 - 40.

36. Fidder A et al. Biomonitoring of exposure to lewisite based on adducts of haemoglobin. Archives of Toxicology, 2000, 74:207 - 214.

37. Morimoto F, Shimazu T, Yoshioka T. Intoxication of VX in humans. American Journal of Emergency Medicine, 1999, 17:493 - 494.

38. Nozaki H et al. A case of VX poisoning and the difference from sarín. Lancet, 1995, 346:698 - 699.

39. Lallement G et al. Review of the value of gacyclidine (GK-11) as adjuvant medication to conventional treatments of organophosphate poisoning: primate experiments mimicking various scenarios of military or terrorist attack by soman. Neurotoxicology, 1999, 20:675 - 684.

40. Grob D. Anticholinesterase intoxication in man and its treatment. In: Koelle GB, ed. Handbuch der experimentellen Pharmakologie. [Handbook of experimental pharmacology.] Berlin, Springer Verlag, 1963.

41. Polhuijs M, Langenberg JP, Benschop HP. New method for the retrospective detection of exposure to organophosphorus anticholinesterases: application to alleged victims of Japanese terrorists. Toxicology and Applied Pharmacology, 1997, 146:156 - 161.

42. Minami M et al. Method for the analysis of the methylphosphonic acid metabolites of sarín and its ethanol-substituted analogue in urine as applied to the victims of the Tokyo sarín disaster. Journal of Chromatography B Biomedical Sciences and Applications, 1997, 695:237 - 244.

43. Nagao M et al. Definite evidence for the acute sarín poisoning in the Tokyo subway. Toxicology and Applied Pharmacology, 1997, 144:198 - 203.

44. Shih TS, McDonough JH Jr, Koplovitz I. Anticonvulsants for soman-induced seizure activity. Journal of Biomedical Science, 1999, 6:86 - 96.

45. NATO handbook on the medical aspects of NBC defensive operations. Part II - Biological. Brussels, North Atlantic Treaty Organization, 1996 (NATO Amed P-6(B)).

46. Chemical warfare. London, Defence Research Policy Committee, United Kingdom Ministry of Defence, 1960 (memorandum DEFE 10/382, held by Public Record Office, Ruskin Avenue, Richmond TW9 4DU, England).

47. Ellenhorn MD et al. Ellenhorn's medical toxicology: diagnosis and treatment of human poisoning, 2nd ed. Baltimore, MD, Williams & Wilkins, 1997:387 - 391.

48. Gilman AG et al., eds. Goodman & Gilman's pharmacological basis of thereapeutics, 8th ed. New York, Pergamon, 1990.

49. Haddad LM. Clinical management of poisoning and drug overdose, 2nd ed. Philadelphia, PA, Saunders, 1990:59 - 76.

50. Sun J. Lysergic acid diethylamide (LSD) determination by GC-MS. American Clinical Laboratory, 1989, 8:24 - 27.

51. Ketchum JS. The human assessment of BZ. Edgewood Arsenal, Aberdeen, MD, US Army Chemical Research and Development Laboratory, 1963 (CRDL Technical Memorandum 20-29).

52. Panel on Anticholinesterase Chemicals, Panel on Anticholinergic Chemicals, Committee on Toxicology, Board on Toxicology and Environmental Health Hazards. Possible long-term health effects of short-term exposure to chemical agentes, Vol. 1. Washington, DC, National Academy Press, 1982.

53. Report of the mission dispatched by the Secretary-General to investigate an alleged use of chemical weapons in Mozambique. New York, United Nations, 1992 (Security Council Report S/24065).

54. Andersson G, Persson SA. Final report of the experts appointed by ASDI to assist the government of Mozambique in order to investigate the alleged use of chemical warfare agent(s) in the Ngungue incident. Stockholm, National Defence Research Establishment, 1992.

55. Hay A. Surviving the impossible. Medicine, Conflict and Survival, 1998, 14:120 - 155.

56. NATO handbook on the medical aspects of NBC defensive operations. AMedP-6. Washing- ton, DC, Departments of the Army, the Navy and the Air Force, 1973.

57. Olajos EJ, Salem H. Riot control agentes: pharmacology, toxicology, biochemistry and chemistry. Journal of Applied Toxicology, 2000, 21:355 - 391.

58. Reay DT et al. Positional asphyxia during law enforcement transport. American Journal of Forensic Medicine and Pathology, 1992, 13:90 - 97.

59. Pollanen MS et al. Unexpected death related to restraint for excited delirium: a retrospective study of deaths in police custody and in the community. Canadian Medical Association Journal, 1998, 158:1603 - 1607.

60. Haber LF. The poisonous cloud. Oxford, Clarendon Press, 1986.

61. Systematic identification of chemical warfare agentes. B.3: Identification of non-phosphates. Helsinki, Ministry for Foreign Affairs, 1982.

62. Ballantyne B. Riot control agentes - biomedical and health aspects of the use of chemicals in civil disturbances. Medical annual, 1977:7 - 14.

63. Gaskins JR et al. Lacrimating agentes (CS and CN) in rats and rabbits. Acute effects on mouth, eyes, and skin. Archives of Environmental Health, 1972, 24:449 - 454.

64. Vaca FE, Myers JH, Langdorf M. Delayed pulmonary oedema and bronchospasm after accidental lacrimógeno exposure. American Journal of Emergency Medicine, 1996, 14:402 - 405.

65. Stein AA, Kirwan WE. Chloroacetophenone (tear gas) poisoning: a clinicopathologic report. Journal of Forensic Sciences, 1964, 9:374 - 382.

66. Hu H et al. Tear gas - harassing agent or toxic chemical weapon? Journal of the American Medical Association, 1989, 262:660 - 663.

67. Parneix-Spake A et al. Severe cutaneous reactions to self-defense sprays [letter]. Archives of Dermatology, 1993, 129:913.

68. Ballantyne B, Gall D, Robson DC. Effects on man of drenching with dilute solutions of o-chlorobenzylidene malonitrile (CS) and dibenz(b,f)-1,4-oxazepine (CR). Medicine, Science and the Law, 1976, 16:159 - 170.

69. Hu J. Toxicodynamics of riot-control agentes (lacrimógenos). In: Somani SM, ed. Chemical warfare agentes. San Diego, CA, Academic Press, 1992:271 - 288.

70. Jones GRN. CS sprays: antidote and decontaminant. Lancet, 1996, 347:968 - 969.

71. Biskup RK et al. Toxicity of 1% CR in propylene glycol/water (80/20). Edgewood Arsenal, Aberdeen Proving Ground, Aberdeen, MD, 1975 (Technical Report EB-TR-75009).

72. Ballantyne B, Beswick FW, Thomas DP. The presentation and management of individuals contaminated with solutions of dibenzoxazepine. Medicine, Science and the Law, 1973, 13:265 - 268.

73. Upshall DG. The effects of dibenz(b,f)-1,4-oxazepine (CR) upon rat and rabbit embryonic development. Toxicology and Applied Pharmacology, 1974, 29:301 - 311.

74. Higginbottom R, Suschitzsky H. Syntheses of heterocyclic compounds. Part II: Cyclisation of o-nitrophenyl oxygen ethers. Journal of the Chemical Society, 1962, 962:2367 - 2379.

75. Johnson DW, Haley MV, Landis WG. The aquatic toxicity of the sensory irritant and riot control agent dibenz(b,f)-1,4-oxazepine. In: Landis WG, van der Schalie WH, eds. Aquatic toxicology and risk assessment, Vol. 13. Philadelphia, PA, American Society for Testing and Materials, 1990:1767 - 1788.

76. Govindarajan VS, Sathyanarayana MN. Capsicum - production, technology, chemistry, and quality. Part V. Impact on physiology, pharmacology, nutrition, and metabolism; structure, pungency, pain, and desensitization sequences. Critical Reviews in Food Science and Nutrition, 1991, 29:435 - 474.

77. Salem H et al. Capsaicin toxicology overview. Edgewood Research Development and Engineering Center, Aberdeen Proving Ground, Aberdeen, MD, 1994 (MD ERDEC-TR-199).

78. Busker RW, van Helden HPM. Toxicologic evaluation of pepper spray as a possible weapon for the Dutch police force: risk assessment and efficacy. American Journal of Forensic Medicine and Pathology, 1998, 19:309 - 316.

79. Govindarajan VS. Capsicum - production, technology, chemistry, and quality. Part III. Chemistry of the color, aroma and pungency stimuli. Critical Reviews in Food Science and Nutrition, 1986, 24:245 - 355.

to previous section to next section

Please provide your feedback   English  |  French  |  Spanish